155 related articles for article (PubMed ID: 11869402)
41. Adrenal function in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient conditions.
Breborowicz A; Niedziela M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):781-9. PubMed ID: 17849740
[TBL] [Abstract][Full Text] [Related]
42. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
Wilson AM; Lipworth BJ
Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
[TBL] [Abstract][Full Text] [Related]
43. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
[TBL] [Abstract][Full Text] [Related]
44. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
46. No effect of fluticasone propionate on linear growth in preschool children with asthma.
Stefanovic IM; Verona E; Cicak B; Vrsalovic R
Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
[TBL] [Abstract][Full Text] [Related]
47. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
[TBL] [Abstract][Full Text] [Related]
48. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children.
Priftis KN; Papadimitriou A; Gatsopoulou E; Yiallouros PK; Fretzayas A; Nicolaidou P
Eur Respir J; 2006 Feb; 27(2):316-20. PubMed ID: 16452586
[TBL] [Abstract][Full Text] [Related]
49. Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature.
Schwartz RH; Neacsu O; Ascher DP; Alpan O
Clin Pediatr (Phila); 2012 Dec; 51(12):1184-90. PubMed ID: 23043135
[TBL] [Abstract][Full Text] [Related]
50. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
51. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ; Grove A; Cargill RI; Lipworth BJ
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
[TBL] [Abstract][Full Text] [Related]
53. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
54. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
Holliday SM; Faulds D; Sorkin EM
Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[TBL] [Abstract][Full Text] [Related]
56. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ; Martin RJ; King TS; Boushey HA; Cherniack RM; Chinchilli VM; Craig TJ; Dolovich M; Drazen JM; Fagan JK; Fahy JV; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lazarus SC; Lemanske RF; Mauger E; Peters SP; Sorkness CA;
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[TBL] [Abstract][Full Text] [Related]
57. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
[TBL] [Abstract][Full Text] [Related]
58. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.
Mahachoklertwattana P; Sudkronrayudh K; Direkwattanachai C; Choubtum L; Okascharoen C
Arch Dis Child; 2004 Nov; 89(11):1055-8. PubMed ID: 15499064
[TBL] [Abstract][Full Text] [Related]
59. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.
Paton J; Jardine E; McNeill E; Beaton S; Galloway P; Young D; Donaldson M
Arch Dis Child; 2006 Oct; 91(10):808-13. PubMed ID: 16556614
[TBL] [Abstract][Full Text] [Related]
60. Safety of the newer inhaled corticosteroids in childhood asthma.
Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
